Skip to main content
FinSpry Logo
FinSpry
PTCT logo
PTCT
(NASDAQ)
PTC Therapeutics, Inc.
$73.31-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

PTC Therapeutics (PTCT) Stock Price & Financial Analysis

PTC Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$72.86 - $75.00
52-Week High$90.87
52-Week Low$43.18
Open$75.00
Volume763.59K
Average Volume (3M)1.71M
Market Cap6.75B
Shares Outstanding92.02M
Price to Sales (P/S)6.69
Price to Book (P/B)-40.80
EV/EBITDA86.67
Revenue (TTM)1.01B
Net Income (TTM)-38.38M
Free Cash Flow (TTM)-327.53M
EPS (TTM)$-0.45
Profit Margin-3.80%
Operating Margin11.52%
50-Day MA$77.27
200-Day MA$73.23
52-Week Change61.55%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About PTC Therapeutics

What is the current stock price for PTCT?

As of the latest trading session, PTCT stock trades at $73.70. The 52-week range is $43.18–$90.87, with a day range of $72.86–$75.00.

What is the P/E ratio for PTCT?

The P/E ratio (Price-to-Earnings) for PTCT is shown in the Key Statistics section. This valuation metric helps compare PTC Therapeutics, Inc. to industry peers.

Does PTCT pay dividends?

PTC Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PTCT?

Based on 5 analysts, the consensus for PTCT is Buy.

What is the market cap of PTCT?

PTC Therapeutics's market capitalization is $6.78B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.